Tag Archives: U.S.

Sanofi and Regeneron's Dupixent gets more positive feedback from U.S. FDA

FILE PHOTO: The logo of Sanofi is pictured during the Viva Tech start-up and technology summit in Paris, France, May 25, 2018. REUTERS/Charles Platiau/File Photo PARIS (Reuters) – The U.S. Food & Drug Administration (FDA) regulator has given more positive feedback on the Dupixent eczema treatment being developed by drugmakers Sanofi and Regeneron, the companies… Read More »

The New Health Care: The U.S. Is Failing in Infant Mortality, Starting at One Month Old

Another such review examined how the number of prenatal visits affected infant mortality. Seven studies involved more than 60,000 women in countries of varying income. There was no difference in high-income countries in the number of deaths of those who had more or fewer visits (although the number of deaths over all was low). In… Read More »